mRNA |
JW-480 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.2 |
mRNA |
Vandetanib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.049 |
0.2 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
BRD-K14844214 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |